Anti-Human TGF-β Therapeutic Antibody (Fresolimumab)

Recombinant monoclonal antibody to TGF-beta. Fresolimumab (GC1008) is a human monoclonal antibody and an immunomodulator. It is intended for the treatment of idiopathic pulmonary fibrosis (IPF), focal segmental glomerulosclerosis, and cancer (kidney cancer and melanoma).
Supplier Creative Biolabs
Product # TAB-140
Pricing Inquiry
Host Human
Target TGF-beta
Species Reactivity Human
Type IgG4 - kappa
Applications Neut, ELISA, IF, IP, FuncS, FC, ICC, PK, PET
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback